Table DF1: Brachytherapy — Hepatobiliary System and Pancreas
Row 1
- Treatment Site:
0 Liver; 1 Gallbladder; 2 Bile Ducts; 3 Pancreas - Modality Qualifier:
9 High Dose Rate (HDR) - Isotope:
7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); B Palladium 103 (Pd-103); C Californium 252 (Cf-252); Y Other Isotope - Qualifier:
Z None
Row 2
- Treatment Site:
0 Liver; 1 Gallbladder; 2 Bile Ducts; 3 Pancreas - Modality Qualifier:
B Low Dose Rate (LDR) - Isotope:
6 Cesium 131 (Cs-131); 7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); C Californium 252 (Cf-252); Y Other Isotope - Qualifier:
Z None
Row 3
- Treatment Site:
0 Liver; 1 Gallbladder; 2 Bile Ducts; 3 Pancreas - Modality Qualifier:
B Low Dose Rate (LDR) - Isotope:
B Palladium 103 (Pd-103) - Qualifier:
1 Unidirectional Source; Z None